SBRA — Sabra Health Care REIT, Inc. stock price, charts and financials

NASDAQ·Real Estate·REIT - Healthcare Facilities·USA

Latest market price

20.15

+0.06+0.30%

Overview Short InterestFilings

SBRAQT45Sabra Health Care REIT, Inc.·NASDAQ

Overview Short InterestFilings

20.15+0.30%

Loading chart...

Signal & projected range

Analyst consensus risingHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

HR-0.54%$18.40 NHI+1.57%$69.23 MPW+0.00%$5.02 CTRE+0.50%$38.17 AHR+0.02%$53.15 LTC+0.97%$43.50 MPT+6.19%$3.60 DHC+2.39%$8.13

Snapshot

Index	-	P/E	77.50	EPS (ttm)	0.26	Insider Own	1.85%	Shs Outstand	252.19M	Perf Week	-3.26%

Market Cap	5.08B	Forward P/E	26.32	EPS next Y	0.77	Insider Trans	-4.61%	Shs Float	250.55M	Perf Month	-0.89%

Enterprise Value	7.49B	PEG	-	EPS next Q	0.17	Inst Own	-	Short Float	7.73%	Perf Quarter	11.63%

Income	66.00M	P/S	5.91	EPS this Y	80.94%	Inst Trans	-	Short Ratio	6.28	Perf Half Y	-2.33%

Sales	860.00M	P/B	1.85	EPS next Y	62.74%	ROA	1.19%	Short Interest	19.38M	Perf YTD	6.39%

Book/sh	10.91	P/C	21.90	EPS next 5Y	-	ROE	2.34%	52W High	22.77 -11.51%	Perf Year	6.78%

Cash/sh	0.92	P/FCF	14.94	EPS past 3/5Y	- -0.91%	ROIC	23.27%	52W Low	17.17 17.36%	Perf 3Y	52.65%

Dividend Est.	1.20 (5.96%)	EV/EBITDA	20.88	Sales past 3/5Y	7.43% 5.29%	Gross Margin	72.58%	Volatility	2.21% 1.85%	Perf 5Y	21.75%

Dividend TTM	1.20 (5.96%)	EV/Sales	8.71	EPS Y/Y TTM	-51.85%	Oper. Margin	11.84%	ATR (14)	0.43	Perf 10Y	-23.44%

Dividend Ex-Date	Aug 14, 2026	Quick Ratio	43.68	Sales Y/Y TTM	22.33%	Profit Margin	7.61%	RSI (14)	40.71	Recom	2.69

Dividend Gr. 3/5Y	0.00% -2.33%	Current Ratio	43.68	EPS Q/Q	-135.71%	SMA20	-2.28%	Beta	0.61	Target Price	22.57

Payout	455.46%	Debt/Eq	0.90	Sales Q/Q	24.87%	SMA50	-2.70%	Rel Volume	0.70	Prev Close	20.09

Employees	58	LT Debt/Eq	0.83	Earnings	Nov 04	SMA200	1.15%	Avg Volume	2.86M	Price	20.15

IPO Date	Apr 02, 2002	Option/Short	Yes / Yes	EPS/Sales Surpr.	-158.45% 7.51%	Net Debt/EBITDA	6.73	Volume	2,011,621	Change	0.30%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Aug-31-26	Reiterated	Mizuho Securities	Neutral	$20 → $21
Aug-31-26	Reiterated	Barclays	Equal Weight	$21 → $23
Aug-06-26	Upgrade	Raymond James	Underperform → Market Perform
Jul-22-26	Reiterated	UBS	Neutral	$22 → $25
Jul-22-26	Reiterated	Robert W. Baird		$22 → $23
Jul-08-26	Upgrade	Truist Securities	Hold → Buy	$21 → $22
Jul-07-26	Reiterated	Barclays	Equal Weight	$21
Jun-23-26	Downgrade	Citigroup	Buy → Neutral
Jun-18-26	Reiterated	UBS	Neutral	$22 → $19
May-21-26	Reiterated	Scotiabank	Sector Perform	$15 → $22

Latest News· Times ET

Sep-15-26

Sep-15-2607:40PM

Sabra Health Care: This Silver Tsunami Opportunity Is Just Getting StartedSeekingAlpha

12:48AM

Sabra Health Care REIT: This 5.85% Healthcare REIT Is Undervaluedseekingalpha.com

Sep-10-26

Sep-10-2603:45AM

3 More Buys In Senior Housing REITsSeekingAlpha

Sep-09-26

Sep-09-2605:05AM

Sabra Health Care REIT, Inc., Issues Business Update and will Participate in the BofA Securities 2026 Global Real Estate Conferencebusinesswire.com

Aug-31-26

Aug-31-2604:52AM

Barclays Maintains Equal-Weight on Sabra Health Care REIT, Raises Price Target to $23Benzinga

Aug-10-26

Aug-10-2609:29PM

Sabra Health Care REIT (SBRA) Q2 2026 Earnings Call TranscriptYahoo

Aug-09-26

Aug-09-2605:00AM

Return Of The Bad News BullsSeekingAlpha

Aug-06-26

Aug-06-2611:55PM

Amundi Increases Stock Holdings in Sabra Healthcare REIT, Inc. $SBRAdefenseworld.net

03:59AM

Here Are Thursday’s Top Wall Street Analyst Research Calls: AppLovin, Charles River, Global Payments, HubSpot, Insulet Corporation, Roper Technologies, Sabra Health Care, Western Digital, Zillow Group, and More247wallst.com

Aug-04-26

Aug-04-2601:40PM

Sabra Health Care REIT, Inc. (SBRA) Q2 2026 Earnings Call Transcriptseekingalpha.com

11:05AM

Sabra Healthcare REIT Q2 Earnings Call Highlightsmarketbeat.com

Aug-03-26

Aug-03-2604:47PM

Sabra Health Care REIT (NASDAQ:SBRA) Q2 Results Beat on Revenue and AFFO Despite Loan Loss ProvisionChartMill

02:46PM

Sabra Healthcare (SBRA) Tops Q2 FFO and Revenue Estimateszacks.com

12:05PM

Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidancebusinesswire.com

Jul-31-26

Jul-31-2608:40AM

HPP vs. SBRA: Which Stock Is the Better Value Option?zacks.com

Company

Sabra Health Care REIT, Inc. engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	860	775	703	—	—	—	—	—	—
Cost of Goods Sold Incl. D&A	236	271	227	—	—	—	—	—	—
Gross Profit	623	504	476	—	—	—	—	—	—
Selling, General and Administrative Excl. Other	61	54	50	—	—	—	—	—	—
Research and Development	0	0	0	—	—	—	—	—	—
Other Operating Expense	462	186	169	—	—	—	—	—	—
Operating Income	102	264	257	—	—	—	—	—	—
Interest Expense	88	112	115	—	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	49	6	-14	—	—	—	—	—	—
Net Income Before Taxes	63	157	128	—	—	—	—	—	—
Income Taxes	-1	2	1	—	—	—	—	—	—
Consolidated Net Income	66	156	127	—	—	—	—	—	—
Net Income From Continuing Operations	64	156	127	—	—	—	—	—	—
Net Income	66	156	127	—	—	—	—	—	—
EPS (Recurring)	0.26	0.64	0.54	—	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	0.26	0.64	0.54	—	—	—	—	—	—
EPS (Diluted)	0.26	0.64	0.54	—	—	—	—	—	—
EBITDA	359	457	413	—	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	77.50	29.59	32.07	—	—	—	—	—	—
Price To Sales Ratio	5.90	5.89	5.74	—	—	—	—	—	—
Gross Margin	72.44	65.03	67.71	—	—	—	—	—	—
Operating Margin	11.86	34.06	36.56	—	—	—	—	—	—
Net Margin	7.67	20.13	18.07	—	—	—	—	—	—
Shares Outstanding	252	241	233	—	—	—	—	—	—
Market Capitalization	5,078	4,565	4,036	—	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MATROS RICHARD K	Chair, CEO and President	Sep 08 '26	Sale	20.83	200,000	4,166,000	1,657,686	Sep 09
FLORES JESSICA	Executive VP & CAO	Mar 25 '26	Sale	19.86	15,231	302,488	71,709	Mar 26
FOSTER MICHAEL J	Director	May 20 '25	Sale	18.22	11,000	200,376	64,725	May 22
Cusack Catherine	Director	Feb 24 '25	Buy	15.92	1,500	23,880	60,583	Feb 25
Cusack Catherine	Director	Feb 21 '25	Buy	16.43	1,000	16,435	59,083	Feb 25
Cusack Catherine	Director	May 22 '24	Buy	14.43	7,000	101,010	46,385	May 23
FOSTER MICHAEL J	Director	May 14 '24	Sale	14.68	10,000	146,830	63,923	May 17
Costa Michael Lourenco	Executive VP, CFO & Secretary	Sep 01 '23	Buy	12.63	1,947	24,591	183,218	Sep 05

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.